Imprimisrx, Llc V. Osrx, Inc. Et Al

Case Background

On July 20, 2021, Plaintiff Lori LaRock filed a Trademark Infringement lawsuit in the United States District Court, Southern District of California (Case number: 3:21cv1305). This case was assigned to Judge Cynthia Bashant and referred to Magistrate Judge David D. Leshner.

Cause

In this case, ImprimisRx, LLC, a leading compounding pharmacy, alleged that OSRX, Inc. and Ocular Science, Inc. engaged in unfair competition, false advertising, and intellectual property violations. ImprimisRx specializes in high-quality compounded medications used in ophthalmology and optometry, holding trademarks and copyrights that reflected its innovations and trusted formulations. OSRX allegedly duplicated these formulations and infringed on ImprimisRx’s trademarks, promoting false claims about their safety and efficacy without FDA approval. ImprimisRx argued that OSRX’s deceptive practices undermined its competitive advantage and goodwill in the pharmaceutical market.

Injuries

ImprimisRx reported significant harm to its business, reputation, and trademarks due to OSRX’s actions. OSRX allegedly misled healthcare providers and patients by making unverified claims about their compounded medications, violating labeling and promotional rules. The widespread dissemination of false advertising created confusion in the marketplace, leading to lost sales and damage to ImprimisRx’s standing in the pharmaceutical and healthcare sectors. Additionally, OSRX’s trademark infringement and copyright violations dil